Furyk O. Clinical-pathogenetic significance of compensatory-adaptive mechanisms in patients with acute hepatitis B against toxic liver damage.

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0413U005615

Thesis Registration Form

0413U005615.pdf

Applicant for

Specialization

  • 14.01.13 - Інфекційні хвороби

24-09-2013

Specialized Academic Board

Д 58.601.02

Essay

The results of research of clinical-pathogenetic links of acute hepatitis B, depending on the presence of chronic use of alcohol hepatotoxic doses are uncovered in the dissertation. Complex investigation of cytokine (interleukins 2, 6, 8, tumor necrotic factor alpha), neurohumoral (spectral parameters of heart rate variability, cortisol) and prooxidant-antioxidant parameters (oxidative modification of proteins, nitrite, catalase), addition of L-arginine hydrochloride and thiotriazoline was done in these patients. The idea of the clinical and pathogenetic features of acute hepatitis B with chronic use of alcohol hepatotoxic doses has been extended, which gave the chance to show effectiveness additional inclusion these drugs in complex of basic pathogenetic treatment.

Read more

Files

aref.doc

dis.doc

Similar theses

0421U103752

Melnyk Larisa Pavlivna

Clinical and pathogenetic aspects of the combination of Lyme borreliosis, tuberculosis and giardiasis

0421U103016

Zots Yana Viktorivna

Diagnostic significance of stress-associated hormones in patients with acute bacterial meningitis

0521U101642

Shevchenko-Makarenko Olha Petrivna

Stratification of clinical-epidemiological and epigenetic factors for the personalization of management of patients with chronic viral hepatitis C

0421U102949

Shevelova Olena Volodymyrivna

Significance of the primary level of clinical, immunological and virological indicators of HIV status in predicting the effectiveness of highly active antiretroviral therapy and the risks of an unfavorable course of the disease

0421U102856

Kushnierova Olena An.

Clinical and pathogenetic features of the Epstein-Barr viral infection course in HIV-infected patients